Hyliion (NYSE:HYLN) Cut to Sell at Wall Street Zen

Wall Street Zen cut shares of Hyliion (NYSE:HYLN) from a hold rating to a sell rating in a research report report published on Saturday morning.

HYLN has been the subject of several other reports. Zacks Research upgraded Hyliion from a “strong sell” rating to a “hold” rating in a research note on Wednesday, August 13th. Johnson Rice began coverage on Hyliion in a research note on Tuesday, October 21st. They issued a “buy” rating and a $5.00 target price for the company. One equities research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $5.00.

Hyliion Trading Down 2.6%

Hyliion stock opened at $2.22 on Friday. The firm has a market capitalization of $389.47 million, a P/E ratio of -6.00 and a beta of 2.51. The stock has a fifty day moving average price of $1.96 and a 200 day moving average price of $1.66. Hyliion has a 52 week low of $1.11 and a 52 week high of $4.09.

Insider Transactions at Hyliion

In other news, Director Richard Joseph Freeland purchased 65,000 shares of the stock in a transaction on Thursday, August 21st. The stock was purchased at an average price of $1.57 per share, with a total value of $102,050.00. Following the completion of the transaction, the director owned 222,798 shares in the company, valued at approximately $349,792.86. The trade was a 41.19% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 20.90% of the company’s stock.

Institutional Investors Weigh In On Hyliion

A number of institutional investors have recently added to or reduced their stakes in the company. Cubist Systematic Strategies LLC purchased a new stake in shares of Hyliion in the first quarter worth about $26,000. SG Americas Securities LLC purchased a new stake in shares of Hyliion in the third quarter worth about $27,000. Brevan Howard Capital Management LP purchased a new stake in shares of Hyliion in the second quarter worth about $30,000. XTX Topco Ltd purchased a new stake in shares of Hyliion in the second quarter worth about $34,000. Finally, O ROURKE & COMPANY Inc boosted its position in shares of Hyliion by 50.0% in the third quarter. O ROURKE & COMPANY Inc now owns 20,006 shares of the company’s stock worth $39,000 after buying an additional 6,670 shares during the period. Hedge funds and other institutional investors own 22.81% of the company’s stock.

Hyliion Company Profile